We estimate that the CEO of Harmony Biosciences Holdings, Inc. ($HRMY), Jeffrey M. Dayno, received a compensation of $7,899,535 in 2025. This is an increase of 9.55% from an estimated $7,145,170 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 03, 2026. Note that parsing errors may occur.
You can track $HRMY on Quiver Quantitative's $HRMY stock dashboard.
$HRMY Stock Insider Trading Activity
$HRMY Stock insiders have traded $HRMY stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $HRMY stock by insiders over the last 6 months:
- SANDIP KAPADIA (CHIEF FINANCIAL OFFICER) has made 0 purchases and 4 sales selling 48,134 shares for an estimated $1,802,845.
- JEFFREY M. DAYNO (PRESIDENT, CEO) has made 0 purchases and 2 sales selling 25,933 shares for an estimated $1,040,102.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HRMY Stock Government Contracts
We have seen $862,014 of award payments to $HRMY over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- BULK - WAKIX 17.8MG TAB: $635,244
- BULK WAKIX: $39,243
- WAKIX 17.8 MG: $10,418
- WAKIX 17.8 MG: $10,418
- WAKIX 17.8 MG: $10,418
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$HRMY Stock Hedge Fund Activity
We have seen 166 institutional investors add shares of $HRMY Stock stock to their portfolio, and 142 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VALOR MANAGEMENT LLC removed 1,151,074 shares (-90.8%) from their portfolio in Q4 2025, for an estimated $43,073,189
- SG AMERICAS SECURITIES, LLC added 938,783 shares (+4102.4%) to their portfolio in Q4 2025, for an estimated $35,129,259
- FMR LLC removed 734,160 shares (-19.1%) from their portfolio in Q4 2025, for an estimated $27,472,267
- ARMISTICE CAPITAL, LLC added 500,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $18,710,000
- AQR CAPITAL MANAGEMENT LLC added 458,321 shares (+128.9%) to their portfolio in Q4 2025, for an estimated $17,150,371
- PACER ADVISORS, INC. removed 362,948 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $13,581,514
- CITADEL ADVISORS LLC added 352,398 shares (+518.1%) to their portfolio in Q4 2025, for an estimated $13,186,733
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HRMY Stock Analyst Ratings
Wall Street analysts have issued reports on $HRMY in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Underperform" rating on 02/25/2026
- Needham issued a "Buy" rating on 02/25/2026
- Truist Securities issued a "Buy" rating on 01/08/2026
- Mizuho issued a "Outperform" rating on 12/01/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/24/2025
To track analyst ratings and price targets for $HRMY Stock, check out Quiver Quantitative's $HRMY forecast page.
$HRMY Stock Price Targets
Multiple analysts have issued price targets for $HRMY recently. We have seen 7 analysts offer price targets for $HRMY in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Jason Gerberry from B of A Securities set a target price of $28.0 on 02/25/2026
- Ami Fadia from Needham set a target price of $44.0 on 02/25/2026
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $55.0 on 02/25/2026
- So Youn Shim from UBS set a target price of $36.0 on 02/25/2026
- Danielle Brill from Truist Securities set a target price of $45.0 on 01/08/2026
- Graig Suvannavejh from Mizuho set a target price of $46.0 on 12/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
